MSB 7.63% $1.34 mesoblast limited

2024 Here we go again., page-265

  1. 6,362 Posts.
    lightbulb Created with Sketch. 379
    Does this potentially mean meso funding two EAPs … one running successfully with GVHD coming into its 4th year kicking real goals in real time still without approval for Ryoncil ….costing $$$$$$ with seemingly no favours from the FDA only to be thinking of another to drain our coffers dry….are we on the FDA’s ‘gaslight path ?’
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.